Clinical

Dataset Information

0

A Trial of JX-594 in Refractory Colorectal Carcinoma


ABSTRACT: The purpose of this study is to: * determine the maximally-tolerated dose (MTD) and/or maximum-feasible dose (MFD) of JX-594 administered by biweekly intravenous (IV) infusion. * determine the safety of JX-594(TK- GM-CSF+ Wyeth strain vaccinia) administered by biweekly IV infusion.

DISEASE(S): Colorectal Carcinoma,Carcinoma,Colorectal Neoplasms

PROVIDER: 2115509 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2012-06-04 | E-GEOD-35590 | biostudies-arrayexpress
2012-06-05 | GSE35590 | GEO
2014-10-01 | GSE60528 | GEO
2019-12-31 | GSE104371 | GEO
2020-02-19 | PXD012794 | Pride
2024-01-01 | GSE208215 | GEO
2014-10-01 | E-GEOD-60528 | biostudies-arrayexpress
2015-01-30 | GSE65425 | GEO
2009-10-22 | GSE18654 | GEO
2021-07-21 | GSE119731 | GEO